136 related articles for article (PubMed ID: 27652266)
21. Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer.
Wang J; Fang R; Wang L; Chen G; Wang H; Wang Z; Zhao D; Pavlov VN; Kabirov I; Wang Z; Guo P; Peng L; Xu W
Cell Physiol Biochem; 2018; 47(4):1565-1577. PubMed ID: 29949785
[TBL] [Abstract][Full Text] [Related]
22. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
[TBL] [Abstract][Full Text] [Related]
23. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
[TBL] [Abstract][Full Text] [Related]
24. Construction of ultrasonic nanobubbles carrying CAIX polypeptides to target carcinoma cells derived from various organs.
Zhu L; Guo Y; Wang L; Fan X; Xiong X; Fang K; Xu D
J Nanobiotechnology; 2017 Sep; 15(1):63. PubMed ID: 28962657
[TBL] [Abstract][Full Text] [Related]
25. CAIX aptamer-functionalized targeted nanobubbles for ultrasound molecular imaging of various tumors.
Zhu L; Wang L; Liu Y; Xu D; Fang K; Guo Y
Int J Nanomedicine; 2018; 13():6481-6495. PubMed ID: 30410333
[TBL] [Abstract][Full Text] [Related]
26. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J
J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724
[TBL] [Abstract][Full Text] [Related]
27. In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging.
Biffi S; Garrovo C; Macor P; Tripodo C; Zorzet S; Secco E; Tedesco F; Lorusso V
Mol Imaging; 2008; 7(6):272-82. PubMed ID: 19123997
[TBL] [Abstract][Full Text] [Related]
28. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.
Lawrentschuk N; Lee FT; Jones G; Rigopoulos A; Mountain A; O'Keefe G; Papenfuss AT; Bolton DM; Davis ID; Scott AM
Urol Oncol; 2011; 29(4):411-20. PubMed ID: 19523858
[TBL] [Abstract][Full Text] [Related]
29. Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor.
Yang X; Minn I; Rowe SP; Banerjee SR; Gorin MA; Brummet M; Lee HS; Koo SM; Sysa-Shah P; Mease RC; Nimmagadda S; Allaf ME; Pomper MG
Oncotarget; 2015 Oct; 6(32):33733-42. PubMed ID: 26418876
[TBL] [Abstract][Full Text] [Related]
30. New Developments in Carbonic Anhydrase IX-Targeted Fluorescence and Nuclear Imaging Agents.
Chen KT; Seimbille Y
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682802
[TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors.
Lv PC; Roy J; Putt KS; Low PS
Mol Pharm; 2016 May; 13(5):1618-25. PubMed ID: 27043317
[TBL] [Abstract][Full Text] [Related]
33. Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5.5-labeled dimeric NGR peptide.
Li G; Xing Y; Wang J; Conti PS; Chen K
Amino Acids; 2014 Jun; 46(6):1547-56. PubMed ID: 24652439
[TBL] [Abstract][Full Text] [Related]
34. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.
Dubois L; Peeters SG; van Kuijk SJ; Yaromina A; Lieuwes NG; Saraya R; Biemans R; Rami M; Parvathaneni NK; Vullo D; Vooijs M; Supuran CT; Winum JY; Lambin P
Radiother Oncol; 2013 Sep; 108(3):523-8. PubMed ID: 23849171
[TBL] [Abstract][Full Text] [Related]
35. Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology.
Xu C; Lo A; Yammanuru A; Tallarico AS; Brady K; Murakami A; Barteneva N; Zhu Q; Marasco WA
PLoS One; 2010 Mar; 5(3):e9625. PubMed ID: 20224781
[TBL] [Abstract][Full Text] [Related]
36. In vivo imaging of the inflammatory receptor CD40 after cerebral ischemia using a fluorescent antibody.
Klohs J; Gräfe M; Graf K; Steinbrink J; Dietrich T; Stibenz D; Bahmani P; Kronenberg G; Harms C; Endres M; Lindauer U; Greger K; Stelzer EH; Dirnagl U; Wunder A
Stroke; 2008 Oct; 39(10):2845-52. PubMed ID: 18635859
[TBL] [Abstract][Full Text] [Related]
37. [(18)F]VM4-037 MicroPET Imaging and Biodistribution of Two In Vivo CAIX-Expressing Tumor Models.
Peeters SG; Dubois L; Lieuwes NG; Laan D; Mooijer M; Schuit RC; Vullo D; Supuran CT; Eriksson J; Windhorst AD; Lambin P
Mol Imaging Biol; 2015 Oct; 17(5):615-9. PubMed ID: 25708744
[TBL] [Abstract][Full Text] [Related]
38. The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.
van Kuijk SJ; Gieling RG; Niemans R; Lieuwes NG; Biemans R; Telfer BA; Haenen GR; Yaromina A; Lambin P; Dubois LJ; Williams KJ
PLoS One; 2016; 11(8):e0161040. PubMed ID: 27513947
[TBL] [Abstract][Full Text] [Related]
39. In vitro evaluation of the monoclonal antibody
Čepa A; Ráliš J; Král V; Paurová M; Kučka J; Humajová J; Lázníček M; Lebeda O
Appl Radiat Isot; 2018 Mar; 133():9-13. PubMed ID: 29272822
[TBL] [Abstract][Full Text] [Related]
40. Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring.
Li D; Liu S; Liu R; Park R; Hughes L; Krasnoperov V; Gill PS; Li Z; Shan H; Conti PS
Mol Pharm; 2013 Jan; 10(1):329-36. PubMed ID: 23211050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
